Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Medicines Company
 More »

  • VC Firm Partners with Amgen, Novartis to Form 15+ Biotech Startups
    high-impact medicines, and catalyze future collaborations around translational research across Atlas Venture's early-stage portfolio," the company further explained in a ...
    5-17-2013
  • VC Investment: Not Quite Dead?
    Another recent winner of Q1 financing was BiOptix Diagnostics, a Boulder, CO, company ... a Kansas City developer or medicines for cats and dogs that in-licenses drugs ...
    5-15-2013
  • Companion Diagnostics: 52 Pick-Up
    ... which AB Science has applied to the European Medicines Agency for marketing authorization. ... (Millennium: The Takeda Oncology Company) Agreement announced April 12, 2012 ...
    5-9-2013
  • Pharma Builds Bridges with Advocacy Groups
    ... separate from drug marketing, though the company acknowledges at least one ... growing pressure to expand access to medicines beyond the poorest patients by ...
    5-7-2013
  • AZ Giving Way to Early-Stage Biopharmas in Cheshire
    resistance to antibiotics and new medicines to tackle viral infections: "A ... a global R&D restructuring in which the company eliminated 1,600 jobs, mainly in the ...
    5-7-2013
  • Celgene, Concert in $300M+ Deuterium Drug Collaboration
    known human pharmacological activity, with the goal of creating new medicines that the company says have potential for enhanced efficacy, better tolerability and improved safety. ...
    5-6-2013
  • Critical Tools for Oligo Characterization
    ... Last year the company entered into a strategic alliance with Marina Biotech. The deal ... production of putative RNA medicines that were previously believed to be not "druggable." ...
    5-1-2013
  • The Globalization of IVD Companies
    ... By analyzing self-reported company-installed base data, we find that out of approximately ... that demand and can afford Western medicines and treatments, which are particularly ...
    5-1-2013
  • Afraxis, Servier Collaborate on Drug Discovery for CNS Disorders
    and safety in CNS disorders, the San Diego-based drug discovery platform company said. ... with the aim of bringing novel medicines into the clinic more rapidly and with ...
    4-30-2013
  • OBT Joins Boehringer Ingelheim in Cancer Drug Collaboration
    we are delighted to collaborate with a company of the caliber of BI in this exciting ... with OBT toward development of cancer medicines and tailored diagnostics based on ...
    4-29-2013
  • Theravance to Split Late-Stage Partnered Assets from Biopharma...
    The second, Theravance Biopharma, will focus on R&D and the commercialization of small molecule medicines, the company added. In a statement issued this week, Theravance said its ...
    4-26-2013
  • GEN | Biolinks
    ... Eleven Biotherapeutics Eli Lilly and Company EMD Millipore Empire State Development ... Information (ELIXIR) European Medicines Agency European Molecular Biology ...
  • Biosimilars: 10 Drugs to Watch
    The world's largest two markets for prescription medicines remain a study in contrasts: ... Hanwha Chemical: HD203 "scheduled for launch," company states on its website without ...
    4-22-2013
  • Merck & Co. Opens Third Manufacturing Plant in China
    is looking to bring more innovative medicines and vaccines to the Chinese people, and ... Over the past two decades, Merck has introduced more than 40 medicines and vaccines in ...
    4-19-2013
  • BMS, Santaris Make Potentially $100M+ mRNA-Targeting Deal
    Santaris Pharma is a biopharmaceutical company focused on developing medicines targeted to disease-related mRNAs and microRNAs. Santaris Pharma will receive an up-front payment of ...
    4-16-2013

  • Journal Articles

  • Safety and Tolerability of an Antiasthma Herbal Formula (ASHMI...
    Kristin Kelly-Pieper, Sangita P. Patil, Paula Busse, Nan Yang, Hugh Sampson, Xiu-Min Li, Juan P. Wisnivesky, Meyer Kattan
    Journal of Alternative and Complementary Medicine, The
    Abstract Background: Complementary and alternative medicines are increasingly used for the ... (ASHMI(tm); Sino-Lion Pharmaceutical Company; Shan Dong China) was demonstrated to be ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll